CRIS Current Research Information System

GRAZI, GIAN LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.514
AS - Asia 9.916
EU - Europa 9.068
AF - Africa 729
SA - Sud America 682
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 7
Totale 34.932
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.409
SG - Singapore 3.159
CN - Cina 2.755
GB - Regno Unito 2.592
VN - Vietnam 2.030
DE - Germania 1.357
SE - Svezia 1.090
IT - Italia 1.008
HK - Hong Kong 748
IN - India 666
UA - Ucraina 633
RU - Federazione Russa 557
BR - Brasile 512
FR - Francia 452
IE - Irlanda 350
NL - Olanda 223
ZA - Sudafrica 209
EE - Estonia 195
TG - Togo 180
FI - Finlandia 171
CI - Costa d'Avorio 167
JP - Giappone 140
KR - Corea 129
CH - Svizzera 124
SC - Seychelles 100
AR - Argentina 83
BG - Bulgaria 80
JO - Giordania 72
CA - Canada 66
BE - Belgio 46
NG - Nigeria 39
IR - Iran 38
AT - Austria 32
ID - Indonesia 32
PL - Polonia 30
EC - Ecuador 29
ES - Italia 28
GR - Grecia 28
BD - Bangladesh 25
MX - Messico 25
RO - Romania 22
IL - Israele 15
LB - Libano 15
CL - Cile 14
PE - Perù 13
UZ - Uzbekistan 13
CO - Colombia 12
HR - Croazia 12
TR - Turchia 12
AU - Australia 10
MY - Malesia 9
PY - Paraguay 9
IQ - Iraq 7
LT - Lituania 7
MA - Marocco 7
EU - Europa 6
PK - Pakistan 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CR - Costa Rica 4
DK - Danimarca 4
EG - Egitto 4
KH - Cambogia 4
PH - Filippine 4
PT - Portogallo 4
TH - Thailandia 4
UY - Uruguay 4
VE - Venezuela 4
AL - Albania 3
AM - Armenia 3
CZ - Repubblica Ceca 3
DM - Dominica 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
BY - Bielorussia 2
DZ - Algeria 2
GA - Gabon 2
LK - Sri Lanka 2
MG - Madagascar 2
MM - Myanmar 2
PS - Palestinian Territory 2
RS - Serbia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
GF - Guiana Francese 1
GH - Ghana 1
GN - Guinea 1
Totale 34.910
Salva come PNG Salva come JPEG
Città #
Southend 2.290
Singapore 2.036
Fairfield 1.856
Ashburn 1.365
Chandler 1.103
Woodbridge 895
Wilmington 794
Seattle 787
Houston 747
Hong Kong 742
Dong Ket 676
Cambridge 620
Santa Clara 612
Princeton 552
Ann Arbor 474
Jacksonville 400
Hefei 364
Beijing 360
Dublin 348
Boardman 343
Ho Chi Minh City 337
Westminster 251
Hanoi 248
Dallas 239
Nanjing 238
Padova 218
Los Angeles 193
Berlin 181
Lomé 180
Abidjan 167
Bologna 163
Munich 156
Helsinki 144
Tokyo 134
Saint Petersburg 132
Seoul 129
Buffalo 124
Jinan 121
Bern 103
San Diego 103
Shenyang 103
Milan 81
Sofia 80
Changsha 74
Amman 72
Nanchang 72
Delhi 71
Hebei 71
New York 70
Mülheim 68
Dearborn 67
Redondo Beach 66
Des Moines 63
Guangzhou 63
Tianjin 62
Florence 60
Turin 56
Frankfurt am Main 51
Zhengzhou 51
Norwalk 47
Shanghai 47
Brussels 45
Haiphong 45
Chicago 44
Jiaxing 44
São Paulo 44
Da Nang 41
Olalla 41
Falls Church 40
London 38
Mahé 38
Medford 37
Abeokuta 36
Verona 34
Yubileyny 34
Phoenix 33
Bengaluru 32
Falkenstein 32
Hangzhou 31
Toronto 31
Haikou 28
Ningbo 28
Redwood City 28
Biên Hòa 25
Bremen 25
Taiyuan 25
Mountain View 23
Ninh Bình 22
Redmond 22
Düsseldorf 20
Fuzhou 20
Paris 20
Taizhou 20
Chengdu 19
Turku 18
Bühl 17
Lanzhou 17
Monmouth Junction 17
Rio de Janeiro 17
Warsaw 17
Totale 23.468
Salva come PNG Salva come JPEG
Nome #
Two cases of severe autoimmune manifestations following virological response to peginterferon alpha- 2b + ribavirin in liver transplanted patients with recurrence of chronic hepatitis C 321
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 266
Prognostic criteria for postoperative mortality in 170 patients undergoing major right hepatectomy 259
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 244
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 243
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. 240
A new liver transplant priority for patients with hepatocellular carcinoma. 237
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 236
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 229
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 228
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 221
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 220
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 217
Surgical therapy for hepatolithiasis: a Western experience. 217
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 215
A partnership model between high- And low-volume hospitals to improve results in hepatobiliary pancreatic surgery 202
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 200
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 197
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 196
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 196
The peculiar aging of human liver: A geroscience perspective within transplant context 196
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 193
Lifelong maintenance of composition, function and cellular/subcellular distribution of proteasomes in human liver 193
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 192
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 192
Coping strategies in intestinal transplantation 191
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 190
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 189
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 188
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 185
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 185
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 185
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 184
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 183
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 179
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 179
Efficacy of MELD score in predicting survival after liver retransplantation. 178
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 177
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. 177
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 177
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 175
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center 175
Using Elderly Donors in Liver Transplantation. 174
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 173
CDKN1C/P57 Is Regulated by the Notch Target Gene Hes1 and Induces Senescence in Human Hepatocellular Carcinoma. 171
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 171
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 171
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. 170
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 170
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 170
Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014 170
Iliac Approach for Vascularization of an Intestinal Graft at Retransplantation. 169
A room for the alpps procedure in patients with HCC 167
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 165
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 165
Split-liver transplantation with pediatric donors: a multicenter experience. 164
Kidney transplantation combined with other organs in bologna: an update. 162
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 161
Ruolo della linfadenectomia in corso di epatectomia per metastasi colorettali. 160
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 160
Alfa-fetoprotein in hepatocellular carcinoma (HCC): diagnostic and prognostic role, clinical and biological predictors. Analysis of 1099 patients. 160
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 159
Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors. 158
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 158
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 157
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine. 157
Detection of recipient's cells in liver graft using antibodies to mismatched HLA class I antigens 157
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 157
Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: a diagnostic and therapeutic challenge. 155
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 155
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 155
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 154
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 154
Medication compliance after liver transplantation: the importance of family support 153
Apoptotic epitope-specific CD8+ T cells and interferon signaling intersect in chronic Hepatitis C virus infection 153
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 152
Liver and partial atrium transplantation for chronic Budd-Chiari syndrome. 151
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. 151
Comparative pre-and intraoperative imaging evaluation in patients with colorectal liver metastases: A prospective study on 128 resected metastases. 151
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 151
Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft. 151
Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. 150
ALPPS for primary and secondary liver tumors 150
ORGAN-SPECIFIC BIOMARKERS OF HUMAN AGING: THE CASE OF LIVER 150
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 149
Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. 148
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. 148
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 148
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. 147
The role of liver resections for metastases from lung carcinoma. 146
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 146
Successful treatment of rhinomaxillary form of mucormycosis infection after liver transplantation: a case report 145
Kidney transplantation combined with other organs: experience of bologna s. Orsola hospital. 145
Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning. 145
The role of liver resections for metastases from lung carcinoma 144
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. 144
Liver Transplantation With Left Lateral Segments in Adults: A Risk or a Possibility? 143
Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. 142
Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples. 142
Model for End-Stage Liver Disease (MELD) System to Allocate and to Share Livers: Experience of Two Italian Centers. 142
Totale 17.683
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.720
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.232 0 0 0 0 0 162 92 169 278 196 176 1.159
2021/20224.519 445 183 348 399 413 247 100 307 135 244 931 767
2022/20234.845 526 754 253 633 264 340 141 317 848 132 402 235
2023/20241.081 93 248 73 110 79 161 47 74 28 74 44 50
2024/20255.361 183 889 450 423 971 317 322 128 91 378 149 1.060
2025/20266.629 1.108 1.085 1.277 923 1.346 890 0 0 0 0 0 0
Totale 35.468